Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
about
Phage therapy: concept to cureThe promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infectionsAdapting Drug Approval Pathways for Bacteriophage-Based TherapeuticsGenetically Engineered Phages: a Review of Advances over the Last DecadeBacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current statusPhage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa InfectionsImportance of prophages to evolution and virulence of bacterial pathogensBacteriophages for managing Shigella in various clinical and non-clinical settingsBacteriophages and Their Immunological Applications against Infectious Threats.Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of BacteremiaMetaPhinder-Identifying Bacteriophage Sequences in Metagenomic Data SetsSynergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.A phage-targeting strategy for the design of spatiotemporal drug delivery from grafted matricesPhenotypic and genotypic variations within a single bacteriophage species.Phage treatment of human infections.Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia.Scaffold-based anti-infection strategies in bone repair.Enumeration of bacteriophage particles: Comparative analysis of the traditional plaque assay and real-time QPCR- and nanosight-based assaysThe isolation and characterization of two Stenotrophomonas maltophilia bacteriophages capable of cross-taxonomic order infectivity.Complete genome sequence of Pseudomonas aeruginosa lytic bacteriophage PA1O which resembles temperate bacteriophage D3112.The Formulation of Bacteriophage in a Semi Solid Preparation for Control of Propionibacterium acnes Growth.Enhancing and initiating phage-based therapies.A Partially Purified Acinetobacter baumannii Phage Preparation Exhibits no Cytotoxicity in 3T3 Mouse Fibroblast Cells.The role of regulated clinical trials in the development of bacteriophage therapeutics.Characterization of Pseudomonas aeruginosa Phage C11 and Identification of Host Genes Required for Virion MaturationThe isolation and characterization of Stenotrophomonas maltophilia T4-like bacteriophage DLP6.Rapid identification of international multidrug-resistant Pseudomonas aeruginosa clones by multiple-locus variable number of tandem repeats analysis and investigation of their susceptibility to lytic bacteriophagesWhat Can We Learn from a Metagenomic Analysis of a Georgian Bacteriophage Cocktail?A Yersinia pestis-specific, lytic phage preparation significantly reduces viable Y. pestis on various hard surfaces experimentally contaminated with the bacterium.Phage therapy of Cronobacter-induced urinary tract infection in mice.Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.Characterization and genomic analysis of two Staphylococcus aureus bacteriophages isolated from poultry/livestock farms.Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections.In vitro Effectiveness of Commercial Bacteriophage Cocktails on Diverse Extended-Spectrum Beta-Lactamase Producing Escherichia coli Strains.Safety assessment of Staphylococcus phages of the family Myoviridae based on complete genome sequences.Prospects of Phage Application in the Treatment of Acne Caused by Propionibacterium acnes.Characterization and complete genome of the virulent Myoviridae phage JD007 active against a variety of Staphylococcus aureus isolates from different hospitals in Shanghai, China.Epidemiology and aetiology of C4-6 disease.Bacteriophages for the treatment of Pseudomonas aeruginosa infections.
P2860
Q21131139-377E3E3C-D9BF-49EB-B968-B9685702B4D2Q21131311-2663E742-A43A-4741-8950-08EF178222B7Q26740597-C499278E-1BA2-4822-865D-ECE694D5FA7BQ26744156-2A212EDC-2A9C-42FF-87C9-3D318264CE38Q26799417-0D7F8022-894B-4F0D-96D8-AF4FD3F989ACQ26823401-D2539379-759E-4840-B246-2DBE74F85229Q28289474-C5855B05-67FD-4872-895D-F1D1FE6778AEQ28384795-E7AD7F7D-88AE-49BD-ACC9-7434C93A6188Q30234522-0ED394C9-D2B8-4049-9029-F402293E274FQ30401003-DCEE49F3-6409-4247-B138-5C3EE5B9082BQ31133755-DC438F55-603E-4444-827E-E0B26C1C352BQ33553795-C751AD9E-2202-4735-95D1-53D18466D26EQ33798541-8AC1E6A6-B3D5-4C82-B3B4-2FC2B851886BQ33823155-C2DCB209-BF57-4429-9D21-73C3C3DACE34Q33853311-47A98419-7EDD-4A8F-B8DB-9CB1A5B8953FQ34254407-E09F0450-0FA6-42BC-8EB0-B194535A6799Q34974472-CDA45E16-D36A-4A72-AC28-97F49AAA807EQ35235414-6DCF6613-A59E-4CAE-897A-B2FECAEB900AQ35754471-A1650C31-D055-4721-9AF5-390A9032C51AQ35763512-23AF02B8-1AAA-4056-BBA9-E69ED38AF852Q35826292-F6E3A8B4-5FA6-408D-BAC1-CBE9C55423DCQ35952871-5419FC50-2A91-4171-B2DF-7986B8DE70E7Q36105880-503AB73C-B374-4612-9A4B-ED657E45B21CQ36106493-962C485E-C031-4FBE-A298-DFDB85EB294AQ36135134-C611148A-DB96-419F-91A9-F0B8E876FA35Q36230120-041121D9-6104-403E-A2E8-C9729FC58E92Q36307585-B04BA583-2C8D-43FC-BCAA-14F918AA94B4Q36396094-CE4A1196-122F-4D18-B661-0CF588A58235Q36403449-9DD1F877-B7BA-4B3A-9252-3204C12BF558Q36489653-0584E83E-5CC1-413D-8EFE-01B6A30488E5Q36516554-3121FF73-5DE0-4120-A298-03C05DBB46B1Q36937446-7434FB03-E24C-49F2-86A6-DD3A9E2A6757Q37257461-D4D0E35D-EA05-4A9C-938F-BA627CEC4727Q37287693-88287B00-365F-4895-8793-967183A857EDQ37389468-31DE37AD-4439-4284-A717-EF3BC98A3D6FQ37602185-ADC9D825-D767-48D0-A2FA-F33B6EF21459Q37629864-9C988EE4-CFEA-4D9B-BB0E-5A7FA3D2CDB9Q37633672-FC3EFC2A-62C2-4936-8525-6396316C4BEFQ37792660-08F56FA1-7424-497D-AC3B-55982BF9C21DQ37853657-0F8A6A81-AEDE-432F-B471-DFCD9FEB5FE6
P2860
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
@ast
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
@en
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
@nl
type
label
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
@ast
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
@en
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
@nl
prefLabel
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
@ast
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
@en
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.
@nl
P2093
P2860
P1476
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
@en
P2093
Kuskowski MA
Sulakvelidze A
Wolcott BM
Wolcott RD
P2860
P304
237-8, 240-3
P356
10.12968/JOWC.2009.18.6.42801
P577
2009-06-01T00:00:00Z